The anti-allergic drug histaglobin inhibits NF-κB nuclear translocation and down-regulates proinflammatory cytokines-Reference-Cited by-同舟云学术

The anti-allergic drug histaglobin inhibits NF-κB nuclear translocation and down-regulates proinflammatory cytokines

Published:2000-10 Issue:10 Volume:22 Page:755-763
ISSN:0192-0561
Container-title:International Journal of Immunopharmacology
language:en
Short-container-title:International Journal of Immunopharmacology

Author:

Ayoub Mohamed,Mittenbühler Klaus,Sütterlin Bernd W,Bessler Wolfgang G

Publisher

Elsevier BV

Subject

Pharmacology,Immunology

Reference39 articles.

1. Changes of histaminopexy in patients with bronchial asthma and chronic urticaria after histaglobin administration;Liebhart;Archivum Immunologiae et Therapiae Experimentalis,1986

2. Therapeutic effectiveness of histaglobin preparations in patients with allergic rhinitis and chronic urticaria;Gushchin;Terapevticheskii Arkhiv,1999

3. Therapy of atopic dermatitis in childern. Study on the use of a desensitizing preparation;Paci;Pediatria Medicae Chirurgica,1986

4. The histamine-fixing power of blood serum. Its modification after an injection of human serum or azoprotein of histamine;Parrot;J. Physiol.,1951

5. Inhibitory effect of histamine-added human gammaglobulin on histamine release from human leucocytes;Ohnishi;Clin. Immunol.,1985

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapy using Histobulin™ in psoriasis: A case report;Clinical Case Reports;2022-05

2. Induction of remission in chronic urticaria by immunotherapy using immunoglobulin/histamine complex (Histobulin™): a case report;Allergy, Asthma & Clinical Immunology;2021-11-12

3. Demystifying Excess Immune Response in COVID-19 to Reposition an Orphan Drug for Down-Regulation of NF-κB: A Systematic Review;Viruses;2021-02-27

4. Immunotherapy using Histobulin in atopic dermatitis;Clinical Case Reports;2020-11-11

5. Allyl methyl disulfide inhibits IL-8 and IP-10 secretion in intestinal epithelial cells via the NF-кB signaling pathway;International Immunopharmacology;2015-07